Else Marit Inderberg
Oslo University Hospital, Norway 

Else Marit Inderberg leads a research group performing immunomonitoring in clinical immunotherapy trials and development of cellular therapy at the Department of Cellular Therapy. The main focus being on T-cell function and therapy as well as the identification of predictive biomarkers of therapy response. She has broad oncology-related clinical trial experience and holds an MSc degree in Immunology from France and a PhD in tumour immunology from the University of Oslo, Norway. She has co-authored several peer-reviewed publications, holds several patents, is member of the editorial board of Frontiers in Immunology, and a recognized reviewer for several journals as well as being scientific adviser for the Norwegian medicines agency.  Else acquired research grants from the Norwegian Research council and local funding agencies.